Abbott Laboratories Corporation

Michael P DeNinno

John W Kebabian

Robert W Schoenleber

Biswanath De

John F DeBernardis

Richard J Perner

Michael D Meyer

David M Stout

Sheela A Thomas

Fatima Z Basha

Michael R Michaelides

Chi-nung W Hsiao

Yvonne Connolly Martin

Stanley DiDomenico, Jr

Novel compounds of Formula (I): ##STR1## or pharmaceutically acceptable salts, esters and amides thereof, wherein A is O, C, CH or CH.sub.2, n is 0 or 1, and the dotted line is a single bond when A is O or CH.sub.2 and a double bond when A is CH or when n=0, A is C and

Dopaminergic compounds

Novel compounds which are selective dopamine agonists are useful for treating disorders characterized by abnormal dopamine levels, such as Parkinson's Disease, as well as cardiovascular disorders.

Dopamine agonists

Growing community of inventors

Wildwood, IL, United States of America

Michael P DeNinno